Oral Strip Delivery Technology

Redwood Scientific Technologies, Inc. develops and markets FDA registered over-the-counter drugs that features oral strip delivery technology.

Redwood Scientific Technologies, Inc. develops and markets over-the-counter drugs that address unmet needs in multibillion dollar markets. Each of the company’s products are registered with the FDA or are scheduled to become registered in the near future.

Product Development

News


Dr. Salah Zaki Appointed Chief Medical Officer at Redwood Scientific Technologies, Inc.

LOS ANGELES, March 4, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has appointed M. Salah Zaki, M.D., as Chief Medical Officer. In this role, Dr. Zaki will oversee scientific research, assist with FDA registration, medical regulation, product development, and global expansion.

read more


Redwood Scientific Technologies, Inc. Unveils Blossom

LOS ANGELES, Feb. 12, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) today announced the unveiling of Blossom: a new oral strip product designed to balance hormones in women.

read more


Redwood Scientific Technologies Designs New Oral Strip Product For Women

LOS ANGELES, Feb. 5, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. announced today the development and launch of a new product designed to help women balance their hormones. This product will be featuring Redwood's innovative oral strip delivery technology.

read more


Redwood Scientific Technologies Announces TBX-FREE Completes FDA Registration

LOS ANGELES, Oct. 13, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. ("Redwood") today announced it has completed the Food & Drug Administration (FDA) registration process for TBX-FREE to be classified as an over-the-counter homeopathic drug under National Drug Code: 69305-001-01. The completion of the registration process is the result of diligent cooperation with FDA counsel in order to obtain compliance for the key ingredient in TBX-FREE.

read more


Redwood Launches Independent Sales Representative Program

LOS ANGELES, July 31, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) announced today that it has launched a nationwide independent sales representative program for Prolongz: the only FDA registered over-the-counter thin film medication for the treatment of premature ejaculation and erectile dysfunction.

read more


Rhonda Pearlman Joins Redwood Scientific Technologies As General Counsel

LOS ANGELES, July 13, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) today announced the appointment of Rhonda Pearlman as General Counsel effective immediately. She will serve on the company's Executive Leadership Team and will report directly to President and Chief Executive Officer Jason Cardiff.

read more


Redwood Scientific Technologies, Inc. Launches TBX-FREE to Aid in Smoking Cessation

LOS ANGELES, July 7, 2015 /PRNewswire/ -- To aid in the ongoing battle against tobacco-based addiction, Redwood Scientific Technologies, Inc. (Redwood) today announced the launch of TBX-FREE: a new thin film over-the-counter smoking cessation medication that features a key ingredient which mimics the sensation of smoking without any of the harmful side effects.

read more


Kevin Harrington Joins Redwood Scientific Technologies Board of Directors

LOS ANGELES, April 8, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced the appointment of Kevin Harrington onto the board of directors, effective immediately. This appointment expands the board to six directors. Kevin Harrington will play an active role overseeing international and domestic retail distribution operations.

read more


Redwood Scientific Technologies Launches Prolongz in the US

LOS ANGELES, Nov. 20, 2014 /PRNewswire/ -- Redwood Scientific Technologies today announced the US launch of Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation. After achieving success with over 100,000 customers outside of the US, Redwood Scientific Technologies has brought Prolongz to the US.

read more


Prolongz Ranked No. 1 in Jordan Whitney's Personal Care Category Three Months in a Row

LOS ANGELES, Dec. 10, 2014 /PRNewswire/ -- Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation, has been ranked No. 1 in the personal care category for July, August and September of 2014 by the Jordan Whitney Greensheet.

read more


Safe Harbor

Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this presentation that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements.

These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, successful completion of the Company’s proposed restructuring, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission. There can be no assurance that our actual results will not differ materially from expectations and other factors more fully described in our public filings with the U.S. Securities and Exchange Commission, which can be reviewed at www.sec.gov.

Safe Harbor

Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this presentation that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements.

These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, successful completion of the Company’s proposed restructuring, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission. There can be no assurance that our actual results will not differ materially from expectations and other factors more fully described in our public filings with the U.S. Securities and Exchange Commission, which can be reviewed at www.sec.gov.